Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06549439
What this trial is testing

EFLASH for Skin Lesions of Malignant Melanomas

Who this might be right for
Metastatic Melanoma
University of Zurich 7
Early research (Phase 1)Study completedNCT01065467
What this trial is testing

Panobinostat (LBH589) in Patients With Metastatic Melanoma

Who this might be right for
MelanomaMalignant Melanoma
Dana-Farber Cancer Institute 16
Not applicableActive Not RecruitingNCT05592639
What this trial is testing

VideoEndoscopic Radical Inguinal Lymphadenectomy for Penile Cancer

Who this might be right for
Penile CancerInguinal LymphadenopathyMelanoma
University College, London 50
Not applicableUnknownNCT02511119
What this trial is testing

Application of Genomic Techniques and Image Processing Using Artificial Intelligence to Obtain a Predictor Model Risk of Melanoma

Who this might be right for
Melanoma
Maimónides Biomedical Research Institute of Córdoba 300
Testing effectiveness (Phase 2)Study completedNCT04305041
What this trial is testing

Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 100
Not applicableNo Longer AvailableNCT04544202
What this trial is testing

Compassionate Use Program BRAF Mutation-positive Patients in the Adjuvant Treatment of Melanoma After Surgical Resection

Who this might be right for
MelanomaAdjuvant
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00101166
What this trial is testing

Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 43
Large-scale testing (Phase 3)Study completedNCT02599402
What this trial is testing

Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 533
Testing effectiveness (Phase 2)Study completedNCT02799901
What this trial is testing

Nivolumab Plus Radiotherapy in Advanced Melanoma

Who this might be right for
Melanoma
Centre Hospitalier Universitaire de Nice 72
Early research (Phase 1)Study completedNCT02120222
What this trial is testing

Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent Melanoma
Kari Kendra 8
Early research (Phase 1)Study completedNCT00574977
What this trial is testing

Safety Study of Modified Vaccinia Virus to Cancer

Who this might be right for
MelanomaBreast CancerHead and Neck Squamous Cell Cancer+3 more
David Bartlett 26
Early research (Phase 1)Study completedNCT03071757
What this trial is testing

The Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 139
Testing effectiveness (Phase 2)Ended earlyNCT00729807
What this trial is testing

0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory Melanoma

Who this might be right for
Melanoma (Skin)
University of Maryland, Baltimore 6
Early research (Phase 1)Study completedNCT05858736
What this trial is testing

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

Who this might be right for
MelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+14 more
OncoC4, Inc. 18
Not applicableEnded earlyNCT00685750
What this trial is testing

Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 88
Not applicableWithdrawnNCT01593579
What this trial is testing

Autonomic Phenotype Before and After Akt Inhibition

Who this might be right for
Diagnosis of Melanoma
Vanderbilt University
Testing effectiveness (Phase 2)Ended earlyNCT03729596
What this trial is testing

MGC018 With or Without MGA012 in Advanced Solid Tumors

Who this might be right for
Squamous Cell Carcinoma of Head and NeckTriple Negative Breast CancerMelanoma+3 more
MacroGenics 143
Not applicableStudy completedNCT02057393
What this trial is testing

Infrared Lymphangiography as a Method of Sentinel Node Identification

Who this might be right for
MelanomaSentinel Node
Milton S. Hershey Medical Center 89
Not applicableLooking for participantsNCT06754904
What this trial is testing

Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node

Who this might be right for
Melanoma, Skin
D.J. (Dirk) Grünhagen 213
Testing effectiveness (Phase 2)Looking for participantsNCT03947385
What this trial is testing

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Who this might be right for
Metastatic Uveal MelanomaCutaneous MelanomaColorectal Cancer+1 more
IDEAYA Biosciences 336
Next Page